Jiayu Wang

10PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 07, 2026
Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer: A Single-Center Pooled Analysis.

|Dec 24, 2025
Trastuzumab and pertuzumab plus carboplatin-based neoadjuvant therapy for HER2-positive breast cancer: a prospective cohort study with integrated genomic and transcriptomic biomarker analysis.

Xiaoyan Qian, Xi Chen, Min Xiao

|Oct 24, 2025
Efficacy and safety of vascular-targeting agents in advanced soft tissue sarcoma: a systematic review and network meta-analysis.

Yan Wang, Hangcheng Xu, Qiang Sa

|Oct 10, 2024
Development of graded prognostic assessment for breast Cancer brain metastasis incorporating extracranial metastatic features: a retrospective analysis of 284 patients.

Yan Wang, Hangcheng Xu, Qiang Sa

|Mar 29, 2023
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer.

Yiqun Han, Jiayu Wang, Binghe Xu

|Feb 25, 2023
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

Zhijun Li, Yiqun Han, Jiayu Wang

Pageof 2

Frequent Collaborators

3 joint publications

Binghe Xu

3 joint publications

Binghe Xu

3 joint publications

Yiqun Han

2 joint publications

Pin Zhang